Antiviral clinical trials taking place in Cleveland
By: Sylvia Rose
Posted: Mar 21, 2020 10:48 PM EDT
-
4:24
Michiana Crime Stoppers shredding event
-
1:16
’IvyCares’ program setting students up for success in and...
-
1:45
Windy and wet this weekend, but unseasonable warmth as well
-
3:13
Local players react to $3 million investment in Byer Softball...
-
0:32
Layoffs at Whirlpool could affect workers in Benton Harbor
-
1:03
Annual District Sisterhood Conference at Ivy Tech empowers students
-
1:49
Back home in downtown South Bend, YMCA to open new location
-
2:16
This week’s ABC57 Cub Reporter is Nicholas Zentz
-
3:05
Amazon Web Services invests $11 billion to build data center...
-
4:05
Riley High School student center stage at the NFL Draft
-
1:35
Rain, wind, and milder temperatures forecast this weekend
-
2:49
Joe Alt expected to be drafted in the first round of NFL Draft
CLEVELAND, Ohio – University Hospitals in Cleveland are taking the next step in fighting COVID-19, securing two clinical trials that will provide an antiviral drug to adults who have been hospitalized with pneumonia due to the virus.
Leaders of the study are hoping to test around 1000 people nationwide.
"Because there's no other treatment now so it's really exciting to see a drug that could hit the virus itself, not just supportive care," said Dr. Grace McComsey, a doctor at University Hospitals.
The trial should provide information on whether the drug can help lower fevers and normalize oxygen saturation in patients.
The drug is federally regulated and was safely tested on more than 500 people during the Ebola outbreak.
Sign up for the ABC 57Newsletter